Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Go back to Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results
(NASDAQ: QNRX) Delayed: 7.01 +0.11 (1.59%)
Previous Close $6.90    52 Week High
Open $6.98    52 Week Low
Day High $7.16    P/E N/A 
Day Low $6.91    EPS
Volume 29,167